State of the art : concise review scientific advances and new frontiers in mesothelioma therapeutics

Mutti, L, Peikert, T, Robinson, BWS, Scherpereel, A, Tsao, AS, de Perrot, M, Woodard, GA, Jablons, DM, Wiens, J, Hirsch, FR, Yang, H, Carbone, M, Thomas, A and Hassan, R 2018, 'State of the art : concise review scientific advances and new frontiers in mesothelioma therapeutics' , Journal of Thoracic Oncology, 13 (9) , pp. 1269-1283.

Full text not available from this repository.


Malignant pleural mesothelioma (MPM) is a rare and aggressive cancer that arises from the mesothelial surface of the pleural and peritoneal cavities, the pericardium, and rarely, the tunica vaginalis. The incidence of MPM is expected to increase worldwide in the next two decades. However, even with the use of multimodality treatment, MPM remains challenging to treat with a 5-year survival rate of less than 5%. The International Association for the Study of Lung Cancer has gathered experts in different areas of mesothelioma research and management to summarize the most significant scientific advances and new frontiers related to mesothelioma therapeutics.

Item Type: Article
Uncontrolled Keywords: Biomarkers, Chemotherapy, Immunotherapy, Malignant pleural mesothelioma, Oncology Therapeutics, Stem Cells, Vaccines
Schools: Schools > School of Environment and Life Sciences
Journal or Publication Title: Journal of Thoracic Oncology
Publisher: Elsevier
ISSN: 1556-1380
Related URLs:
SWORD Depositor: Publications Router
Depositing User: Publications Router
Date Deposited: 17 Jul 2018 12:34
Last Modified: 05 Sep 2018 13:29

Actions (login required)

Edit record (repository staff only) Edit record (repository staff only)